AbbVie Stock Forum

$Novo-Nordisk A/S(NVO.US)$ & $Eli Lilly and Co(LLY.US)$ 's MCap increased by $285 bil in Q1 2024 alone, driven mostly by growth of the GLP-1 franchises,
Revenue from both companies GLP-1 drugs totaled $33.6 bil last yr, an impressive number that almost certainly will grow this yr,
But let's put that $285 bil incr in mkt value into perspective,
$AbbVie(ABBV.US)$ has a $315 bil MCap, not much bigger than the  combined Q1 incr in mkt value for LLY & NVO,
ABBV had $54 bil in revenue in 2023, compared ...

A look at one of the major acquisition deals YTD…👇
$MRTX
Acquired By: Bristol-Myers Squibb$Bristol-Myers Squibb(BMY.US)$
Date: Jan. 23, 2024
Price: $4.8B
$AbbVie(ABBV.US)$$GlaxoSmithKline(GSK.US)$

$AbbVie(ABBV.US)$ to acquire $Landos Biopharma(LABP.US)$
⇒ $137.5M deal at $20.42/sh 💰💰
⇒ strengthens portfolio in inflammatory & autoimmune diseases
⇒ Adds lead asset NX-13 (Ph2 trial UC)
$Nuvation Bio(NUVB.US)$ to acquire AnHeart Therapeutics
⇒ all-stock transaction
⇒ transforms NUVB into late-stage global oncology company
⇒ Includes taletrectinib with ongoing trials NSCLC)
$Novo-Nordisk A/S(NVO.US)$ to acquire Cardior Pharmaceuticals
⇒ 1.025 B euros deal 💰💰
⇒ strengthens pi...

Nvidia $NVIDIA(NVDA.US)$
Walmart $Walmart(WMT.US)$
$Advanced Micro Devices(AMD.US)$
Costco $Costco(COST.US)$
Taiwan Semiconductor $Taiwan Semiconductor(TSM.US)$
CrowdStrike $CrowdStrike(CRWD.US)$
JPMorgan $JPMorgan(JPM.US)$
Airbnb $Airbnb(ABNB.US)$
Palantir $Palantir(PLTR.US)$
Qualcomm $Qualcomm(QCOM.US)$
Target $Target(TGT.US)$
Bank of America $Bank of America(BAC.US)$
Wells Fargo $Wells Fargo & Co(WFC.US)$
Spotify $Spotify Technology(SPOT.US)$
...

$Ironwood Pharmaceuticals(IRWD.US)$ shares sank almost 40% after the drugmaker said its global phase III trial of Apraglutide, a treatment for short bowel syndrome, missed two of its four secondary goals.
That muddies the prospects for the company that's seeking to expand its product pipeline beyond Linzess.
Ironwood, which has been operating at a loss, sourced almost ll of its $117.6 million revenue in 2023 from its collaborati...

$Bristol-Myers Squibb(BMY.US)$
The price action of BMY is finding support near the 47.50 price point. It appears to be forming a double bottom on the charts so far.
There is a bullish divergence on several of the popular oscillating indicators for the weekly candles. The major indicators for the daily candles, like RSI and MACD, are all officially in bullish territory.
Ultimately, the price would need to climb out of the trading ...

Since the beginning of this year, $NVIDIA(NVDA.US)$ has been leading a group of semiconductor and AI stocks to further rise in response to the breakthroughs in AI technology and a booming industry outlook. However, an increasing number of investors have started to fret over the potential risks behind the high valuations of AI stocks and are scouting for alternative investment opportunities. Some of them have shifted their focus to biotech stocks...